Literature DB >> 10773086

Specific binding of Hoechst 33258 to site 1 thymidylate synthase mRNA.

J Cho1, R R Rando.   

Abstract

The translational initiator codon in thymidylate synthetase (TS) mRNA is located in a stem-loop structure with a CC bubble. TS is an important target for anticancer drugs. Aminoglycoside antibiotics have been shown to specifically bind to TS mRNA site 1 constructs and, furthermore, specific binding requires the non-duplex CC bubble region. It is shown here that DNA intercalating agents and DNA minor groove-binding drugs also bind to a TS mRNA site 1 construct. This binding is competitive with aminoglycosides, suggesting that the binding sites overlap. Hoechst 33258 binds with a dissociation constant of 60 nM, a value significantly lower than the approximately 1 microM values found for aminoglycosides. Footprinting and direct binding studies show that the CC bubble is important for binding of the Hoechst compound. However, the exact structure of the bubble is unimportant. Interestingly, mutations in regions adjacent to the bulge also affect binding. These studies point to the important role of non-duplex RNA structures in binding of the DNA minor groove binder Hoechst 33258.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773086      PMCID: PMC105371          DOI: 10.1093/nar/28.10.2158

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  A Structural Basis for RNAminus signLigand Interactions.

Authors:  Christine S. Chow; Felicia M. Bogdan
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.

Authors:  J B Tok; J Cho; R R Rando
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

3.  Major groove accessibility of RNA.

Authors:  K M Weeks; D M Crothers
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

4.  RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide.

Authors:  M I Recht; D Fourmy; S C Blanchard; K D Dahlquist; J D Puglisi
Journal:  J Mol Biol       Date:  1996-10-04       Impact factor: 5.469

5.  Specificity in the binding of aminoglycosides to HIV-RRE RNA.

Authors:  J Cho; R R Rando
Journal:  Biochemistry       Date:  1999-06-29       Impact factor: 3.162

6.  Effects of mutagenesis of a conserved base-paired site near the decoding region of Escherichia coli 16 S ribosomal RNA.

Authors:  E A De Stasio; A E Dahlberg
Journal:  J Mol Biol       Date:  1990-03-05       Impact factor: 5.469

7.  Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.

Authors:  K Hamasaki; J Killian; J Cho; R R Rando
Journal:  Biochemistry       Date:  1998-01-13       Impact factor: 3.162

8.  Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.

Authors:  M L Zapp; S Stern; M R Green
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

9.  Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Authors:  E Chu; D M Koeller; J L Casey; J C Drake; B A Chabner; P C Elwood; S Zinn; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  The different binding modes of Hoechst 33258 to DNA studied by electric linear dichroism.

Authors:  C Bailly; P Colson; J P Hénichart; C Houssier
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

View more
  16 in total

1.  Using modularly assembled ligands to bind RNA internal loops separated by different distances.

Authors:  Jessica L Childs-Disney; Pavel B Tsitovich; Matthew D Disney
Journal:  Chembiochem       Date:  2011-08-09       Impact factor: 3.164

2.  H-gemcitabine: a new gemcitabine prodrug for treating cancer.

Authors:  Madhuri Dasari; Abhinav P Acharya; Dongin Kim; Seungjun Lee; Sungmun Lee; Jeanne Rhea; Ross Molinaro; Niren Murthy
Journal:  Bioconjug Chem       Date:  2012-12-26       Impact factor: 4.774

3.  Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis.

Authors:  Matthew D Disney; Ruth Stephenson; Terry W Wright; Constantine G Haidaris; Douglas H Turner; Francis Gigliotti
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Targeting a regulatory element in human thymidylate synthase mRNA.

Authors:  Nicholas D Brunn; Emily Garcia Sega; Melody B Kao; Thomas Hermann
Journal:  Chembiochem       Date:  2012-11-09       Impact factor: 3.164

5.  Defining the RNA internal loops preferred by benzimidazole derivatives via 2D combinatorial screening and computational analysis.

Authors:  Sai Pradeep Velagapudi; Steven J Seedhouse; Jonathan French; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2011-06-09       Impact factor: 15.419

6.  Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia.

Authors:  LaKechia Grant; Jun Sun; Hongzhi Xu; S H Subramony; Jonathan B Chaires; Michael D Hebert
Journal:  FEBS Lett       Date:  2006-09-15       Impact factor: 4.124

7.  Versatile on-resin synthesis of high mannose glycosylated asparagine with functional handles.

Authors:  Rui Chen; Mark A Pawlicki; Thomas J Tolbert
Journal:  Carbohydr Res       Date:  2013-11-13       Impact factor: 2.104

8.  Pyrrole-imidazole polyamides distinguish between double-helical DNA and RNA.

Authors:  David M Chenoweth; Jordan L Meier; Peter B Dervan
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-14       Impact factor: 15.336

9.  Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.

Authors:  Suzanne G Rzuczek; Mark R Southern; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2015-09-28       Impact factor: 5.100

Review 10.  Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts.

Authors:  Matthew D Disney
Journal:  Drug Discov Today       Date:  2013-08-09       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.